This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Understanding when points offer greater value than cash back can enhance your credit card strategy. Discover these key moments.
28,161 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Walmart and Target face divergent paths in 2026, with valuation gaps, income potential, and strategy shaping whether ...
A sharp drop in Oddity Tech shares sparked questions about the health of a high-growth tech play. Even with solid qua...
The second half of 2026 could reward investors who pick AI stock winners with durable competitive advantages. This gu...
April brought a surprising surge for Tower Semiconductor, defying the notion that only the biggest chipmakers can mov...
As the cost of nursing-home care climbs past six figures annually, medicare won’t touch long-term care costs, forcing...
A single cloud ETF has become the dominant vehicle for exposure as cloud stocks swing in 2026, prompting a shift away...
Bitcoin has endured bear markets and hype cycles alike, and its leadership shows in more than price. Here are four en...
Fresh NAEP data in early 2026 shows a broad but nuanced slide in reading and math for 4th and 8th graders, renewing d...
Markets have celebrated a long rally, but chair nominee kevin warsh's real test may lie in credibility, independence,...
Starbucks shares have slipped sharply in a single week. This guide breaks down what’s driving the move, how to assess...
Imagine a world where your phone pays you back for every scroll and tap. This article dives into Mode Mobile, a specu...